Publication | Closed Access
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
79
Citations
0
References
1970
Year
Medicinal ChemistryMedicinePharmacologyAntitumor AgentPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyDrug Discovery
No additional data available for this publication yet. Check back later!